Avricore Health (AVCRF) Net Income towards Common Stockholders Growth (1y) (2010 - 2026)
Avricore Health (AVCRF) Net Income towards Common Stockholders Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 8.66% |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | 56.76% |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | 33.71% |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 57.67% |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | -9.74% |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 15.11% |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | -11.91% |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 15.10% |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 25.51% |
| 10 | Avricore Health | 3.04 Mn | 3.01 Mn | -6.20 Bn | 48.48% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 48.48% |
| Sep 30, 2025 | -111.85% |
| Jun 30, 2025 | -317.96% |
| Mar 31, 2025 | -144.51% |
| Sep 30, 2024 | -100.00% |
| Jun 30, 2024 | 173.46% |
| Mar 31, 2024 | 182.24% |
| Dec 31, 2023 | -243,052,758.89% |
| Sep 30, 2023 | -100.00% |
| Jun 30, 2023 | -100.00% |
| Mar 31, 2023 | 2.56% |
| Dec 31, 2022 | -764,982,442.48% |
| Sep 30, 2022 | 1,014,066,073.30% |
| Jun 30, 2022 | 5,494,081,337.55% |
| Mar 31, 2022 | -100.01% |
| Dec 31, 2021 | -107.69% |
| Sep 30, 2021 | 88,576,628.44% |
| Jun 30, 2021 | -5,843,911.56% |
| Mar 31, 2021 | 11,876,166.63% |
| Dec 31, 2020 | 2,651.94% |